Product Information
ADAPALENE-BNZYL PEROX 0.3-2.5% is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.6260 per GM under NDC 72578011904. Its NADAC has been published 210 times since Sep 28, 2022.
FDA first approved this application on Jun 3, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 25 mg/g; mg/g
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578011904
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ADAPALENE; BENZOYL PEROXIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214553FDA Approved
6/3/2022
TE Code
AB
On Market Since
6/6/2022
Pharmacological Classes
Price Statistics
The NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has been published 210 times since Sep 28, 2022, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6260 per GM |
|---|---|
| All-time high | $5.6343 (Oct 12, 2022) |
| All-time low | $0.5830 (Nov 20, 2024) |
| 52-week high | $0.7063 |
| 52-week low | $0.5996 |
| Median price | $0.7063 |
| Average price | $1.0538 |
| Largest weekly change | +75.1% (Aug 23, 2023) |
| Weeks tracked | 210 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Adapalene and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADAPALENE-BNZYL PEROX 0.3-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for ADAPALENE-BNZYL PEROX 0.3-2.5%, manufactured by Viona Pharmaceuticals Inc., is $0.6260 per GM (NDC 72578011904), effective Sep 30, 2026.
How has the price of ADAPALENE-BNZYL PEROX 0.3-2.5% changed over time?
Over the history we have for it, the NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has declined 88.9%. It has been tracked across 210 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ADAPALENE-BNZYL PEROX 0.3-2.5%?
Since Sep 28, 2022, the NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has ranged from a low of $0.5830 (Nov 20, 2024) to a high of $5.6343 (Oct 12, 2022), with a median of $0.7063 per GM.
Are there cheaper alternatives to ADAPALENE-BNZYL PEROX 0.3-2.5%?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ADAPALENE-BNZYL PEROX 0.3-2.5% in a comparable dosage form, but none are currently priced below it.
Who manufactures ADAPALENE-BNZYL PEROX 0.3-2.5%?
ADAPALENE-BNZYL PEROX 0.3-2.5% (NDC 72578011904) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.